ALKERMES reported 294.7M in Loan Capital for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Acorda Therapeutics ACOR:US $ 168.37M 2.2M
Amgen AMGN:US $ 31129M 1766M
Biogen BIIB:US $ 7269.2M 2M
Biomarin Pharmaceutical BMRN:US $ 1076.13M 3.02M
Bluebird Bio BLUE:US $ 0M 0M
Bristol Myers Squibb BMY:US $ 44505M 3831M
Eli Lilly And LLY:US $ 16199.6M 387M
Gw Pharmaceuticals GWPH:US $ 14.16M 0.14M
H. Lundbeck A/S LUN:DC 5.75B 61M
Horizon Pharma HZNP:US $ 2562.52M 1559.14M
Intra Cellular Therapies ITCI:US $ 0M 0M
JAZZ PHA JAZZ:US $ 1853.03M 4.52M
Minerva Neurosciences NERV:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 322M 4.1M
Otsuka Holdings 4578:JP Y 179625M 2253M
Regeneron Pharmaceuticals REGN:US $ 1978.9M 716.8M
Revance Therapeutics RVNC:US $ 279.69M 99.17M
Teva Pharmaceutical Industries TEVA:US $ 22288M 443M
Vertex Pharmaceuticals VRTX:US $ 572.86M 33.81M